Skip to content
GLP-1 Desk
Menu
Dispatch #336

Invyncible

Invyncible is a Florida-based telehealth platform offering semaglutide and tirzepatide programs for weight management.

Visit InvyncibleAssume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way.
Semaglutide
$192/mo (0.5 mg dose, compounded)
Tirzepatide
$210/mo (compounded)
Coverage
40 states
Brand-name
Compounded only

Weigh Invyncible against the full ranked field on the best semaglutide providers board, or line it up against its closest alternatives. Or go one-on-one: Invyncible vs CoreAge Rx. Because Invyncible dispenses compounded medication, it’s worth understanding whether compounded GLP-1 is legit and safe.

Desk Score breakdown

Each of the six scored dimensions. See the methodology.

Price transparency30/100
State access66/100
Molecule range72/100
Onboarding speed60/100
Support responsiveness67/100
Licensing & trust66/100

What the Desk likes

  • Corporate parent disclosed (Nationwide Telemedicine, LLC) — better than most competitors hiding behind trade names
  • Physical corporate address published (St. Petersburg, FL)
  • LegitScript verification seal displayed
  • No long-term commitment required
  • Offers both semaglutide and tirzepatide programs

Where points come off

  • Pricing not disclosed on the public site — fully gated behind signup
  • Drug forms (compounded vs brand, injection vs oral) not disclosed
  • 503A vs 503B designation not specified
  • Pharmacy partner not named
  • States served not listed publicly

The Desk's briefing — C

Best for: Readers who want corporate-parent-disclosed Florida GLP-1 platform with LegitScript seal.

Invyncible ranks #336 of 498 providers scored — see #1, CoreAge Rx on the board.

Related dispatches

Everyone else on the board (18)

Pricing and verification reflect Invyncible's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on Invyncible's site. Not medical advice; see our disclosure.

← Back to The Desk